IDH1 and glioma: We identified that 18F-fluorocholine PET/CT offers additional and robust information, with respect to CE-MRI, for finding the subgroup of IDH-wt glioma patients with the worst prognosis, establishing a basis for molecular subtyping using PET that could be defined in future works.